November 18, 2021 6:35 am
Published by mgjay
“The simplSEQ workflow offers many workflow advantages over other methods of cell-free DNA extraction especially speed, simplicity, reproducibility, which are critical as liquid biopsy becomes more common.”
November 10, 2021 11:53 am
Published by mgjay
Company Filed Second Patent Application to Extend Core Technology Applications Murrieta Genomics is pleased to announce that U.S. Patent and... View Article
September 28, 2021 1:35 pm
Published by mgjay
Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an incubator company and subsidiary, will... View Article
January 30, 2021 10:06 am
Published by mgjay
On Friday, January 29th 2021 an article about Murrieta Genomics and our wholly owned subsidiary, SimplSEQ, was published by GenomeWeb.... View Article
December 22, 2020 8:20 am
Published by mgjay
We anticipate a high level of demand for our products, as they will allow labs to save money, time and derive more information from their samples.
July 29, 2020 12:21 pm
Published by mgjay
Murrieta Genomics was recently named as a “company to watch” by The Healthcare Insights, a medical publication that discusses developments... View Article
June 3, 2020 9:31 am
Published by mgjay
Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new patent application for simplified sample... View Article
May 21, 2020 12:05 pm
Published by mgjay
Murrieta Genomics has partnered with Life Science Nation (LSN) and the RESI (Redefining Early Stage Investments) Conference to offer startup... View Article
May 13, 2020 7:18 am
Published by mgjay
The RuleOut team has created a novel approach that can exponentially increase COVID-19 testing capacity.
